Display Settings:

Format

Send to:

Choose Destination
    J Thorac Oncol. 2008 Feb;3(2):190-3.

    2007 Annual Meeting of the National Lung Cancer Partnership: a summary of meeting highlights.

    Source

    National Lung Cancer Partnership, Madison, Wisconsin 53705, USA. Regina@nationallungcancepartnership.org

    Abstract

    This report presents highlights from The National Lung Cancer Partnership's Annual Meeting, held in June 2007 in Chicago. It discusses recent refinements in the histologic, genetic, and epigenetic subtyping of lung cancers and suggests reasons why certain therapies benefit only a subset of lung cancer patients. It also describes new molecular data about the subtype-specific differences in drug resistance among bronchioloalveolar-associated non-small cell lung cancers and discusses strategies to avoid or tackle specific drug-resistant tumors. Finally, it describes new findings about epigenetic differences-specifically in DNA hypermethylation-among lung tumors, including some male/female differences, which may prove useful as biomarkers for diagnosis, prognosis, and prediction of response to treatments.

    PMID:
    18303443
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk